First Time Loading...

Haemato AG
XETRA:HAEK

Watchlist Manager
Haemato AG Logo
Haemato AG
XETRA:HAEK
Watchlist
Price: 21.4 EUR -1.83% Market Closed
Updated: May 4, 2024
Section:
 

Relative Value

The Relative Value of one HAEK stock under the Base Case scenario is 21.81 EUR. Compared to the current market price of 21.4 EUR, Haemato AG is Undervalued by 2%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

HAEK Relative Value
Base Case
21.81 EUR
Undervaluation 2%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

0.4
P/S
P/S
Price to Sales
0.4
vs History
12
vs Industry
81
Median 3Y
0.3
Median 5Y
0
Industry
2.4
Forward
0.4
More Details
11.6
P/E
P/E
Price to Earnings
11.6
vs History
25
vs Industry
39
Median 3Y
11.6
Median 5Y
0
Industry
23.4
Forward
13.4
More Details
9.8
P/OCF
P/OCF
Price to OCF
9.8
vs History
11
vs Industry
36
Median 3Y
4.1
Median 5Y
0
Industry
15.5
More Details
19.5
P/FCFE
P/FCFE
Price to FCFE
19.5
vs History
11
vs Industry
25
Median 3Y
6.6
Median 5Y
0
Industry
23.2
More Details
0.7
P/B
P/B
Price to Book Value
0.7
vs History
33
vs Industry
70
Median 3Y
0.8
Median 5Y
0.7
Industry
2.3
More Details
0.3
EV/S
EV/S
Enterprise Value to Sales
0.3
vs History
12
vs Industry
83
Median 3Y
0.2
Median 5Y
0
Industry
2.5
Forward
0.3
More Details
4.5
EV/GP
EV/GP
Enterprise Value to Gross Profit
4.5
vs History
11
vs Industry
49
Median 3Y
2.7
Median 5Y
0
Industry
5.3
More Details
8.5
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
8.5
vs History
12
vs Industry
37
Median 3Y
6.2
Median 5Y
0
Industry
12.6
More Details
9.6
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
9.6
vs History
12
vs Industry
40
Median 3Y
7.2
Median 5Y
0
Industry
17.2
More Details
7.8
EV/OCF
EV/OCF
Enterprise Value to OCF
7.8
vs History
11
vs Industry
43
Median 3Y
2.9
Median 5Y
0
Industry
15.3
More Details
8.6
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
8.6
vs History
11
vs Industry
36
Median 3Y
2.9
Median 5Y
0
Industry
19.8
More Details
0.6
EV/IC
EV/IC
Enterprise Value to IC
0.6
vs History
22
vs Industry
72
Median 3Y
0.6
Median 5Y
0.5
Industry
2
More Details

Multiples Across Competitors

HAEK Competitors Multiples
Haemato AG Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
DE
Haemato AG
XETRA:HAEK
111.5m EUR 0.4 11.6 8.5 9.6
US
Mckesson Corp
NYSE:MCK
69.3B USD 0.2 23.1 16.1 18.7
US
Cencora Inc
NYSE:COR
44.7B USD 0.2 24.1 16.7 16.7
US
Amerisourcebergen Corp
NYSE:ABC
35.4B USD 0.1 20.9 11.3 15.2
US
Cardinal Health Inc
NYSE:CAH
24.1B USD 0.1 37.8 8.4 11.3
KR
Celltrion Healthcare Co Ltd
KOSDAQ:091990
12.2T KRW 5.9 89.6 59.9 61.9
US
Henry Schein Inc
NASDAQ:HSIC
8.8B USD 0.7 21.1 11.2 15
CN
Huadong Medicine Co Ltd
SZSE:000963
57.6B CNY 1.4 21.3 15.5 15.5
CN
Sinopharm Group Co Ltd
HKEX:1099
61.2B HKD 0.1 6.4 1.5 1.8
IT
Amplifon SpA
MIL:AMP
7.1B EUR 3.2 45.9 14.8 29.2
CN
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
51B CNY 0.2 13.5 8 8

See Also

Summary
HAEK intrinsic value, competitors valuation, and company profile.
DCF Valuation
HAEK stock valuation using Discount Cash Flow valuation method.
Relative Valuation
HAEK stock valuation using valuation multiples.
Wall Street Estimates
HAEK price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
HAEK stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 134,000+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.